[1]
“Tumor necrosis factor-alpha inhibitor combined with methotrexate for ankylosing spondylitis: a systematic review and meta-analysis”, Rheumatol Rep, vol. 6, no. 1, Jun. 2014, doi: 10.4081/rr.2014.5127.